WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2018

Jun 11, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2018-06-08

Reporting Person: FEDERICI WILLIAM J (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-08	Common Stock	M	75662.00	$21.34	Acquired	270681.3342	Direct
2018-06-08	Common Stock	S	42869.00	$96.09	Disposed	227812.3342	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-08	Stock Options (Right to Buy)	$21.34	M	75662.00	Disposed	2020-03-22	Common Stock (75662.00)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1046.4185	Indirect
Common Stock	17060.5586	Indirect

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $95.76 USD to $96.34 USD; the price reported above reflects the weighted average sale price.

F2: This award vests in 4 equal annual installments beginning on 3/22/2011.